Zontivity: Indications, Dosage, Precautions, Adverse Effects
  • Россия
  • Украина

Manufacture: Merck and Co., Inc.
Country: United States
Condition: Peripheral Arterial Disease, Prevention of Atherothrombotic Events, Thromboembolic Disorder
Class: Protease-activated receptor-1 antagonists
Form: Tablets
Ingredients: vorapaxar sulfate, lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, povidone, magnesium stearate, lactose monohydrate, hypromellose, titanium dioxide, triacetin(glycerol triacetate), iron oxide yellow